查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球蛋白质疗法市场规模、份额和行业趋势分析报告：2022-2028 年按产品、应用和地区分列的展望和预测
市场调查报告书
商品编码
1126931

全球蛋白质疗法市场规模、份额和行业趋势分析报告：2022-2028 年按产品、应用和地区分列的展望和预测

Global Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By Product, By Application, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 235 Pages | 订单完成后即时交付

价格

到 2028 年，蛋白质疗法的全球市场规模预计将达到 4902 亿美元，在预测期内以 6.9% 的复合年增长率增长。

在某些情况下缺失或缺失的蛋白质可以用治疗性蛋白质替代。它还可以增加体内有用蛋白质的产生，以减少疾病和化疗的影响。通过基因工程生产的蛋白质可能与它所替代的天然蛋白质非常相似或有所改进。

COVID-19 影响分析

COVID-19 大流行严重损害了世界各地的经济。突如其来的大流行病严重扰乱了许多企业。此外，由于国内各国政府实施封锁，一些製造和生产设施已因疫情而关闭。蛋白质治疗市场在大流行初期也处于动荡之中。封锁导致关键医疗用品的开发和交付出现重大延误。这阻碍了治疗性蛋白质的生产。

市场增长因素

全世界癌症患者的增加

推动蛋白质治疗市场增长的主要因素之一是全球各种癌症的流行。任何可以影响身体任何部位的疾病都称为癌症。肿瘤和恶性肿瘤是用来指这种疾病的其他词。癌症的标誌之一是异常细胞的快速发展，超出其正常边界，侵入其他身体成分，并最终迁移到其他器官。这就是“过渡”。癌症患者死亡的主要原因是癌症在体内广泛扩散。

政府和监管机构越来越重视加快审批流程

在发达国家和发展中国家，数以百万计的患有罕见和復杂疾病的人每天都依赖血浆衍生疗法来获得挽救生命的药物。特别是，即使从全球角度来看，对免疫球蛋白的需求也很大，而且还在继续增长。血浆衍生製剂是通过分离人血浆分离血浆中适当蛋白质的製剂。血液中最大的成分称为血浆，由蛋白质、盐、□和水组成。原发性和继发性免疫缺陷、出血性疾病、抑製剂缺乏和其他罕见疾病均使用血浆衍生药物进行治疗。

市场製约因素

製造和管理成本高

蛋白质治疗市场增长的一个主要挑战是蛋白质治疗的高成本。高昂的产品价格阻碍了患者获得早期和完全康復所需的一些治疗。在一些国家，价格也受法律监管。政府机构通过对该国医疗机构的权力来限製成本，这些机构承担了向消费者销售药品的大部分成本。

产品展望

按产品划分，蛋白质治疗市场分为单克隆抗体、胰岛素、融合蛋白、促红细胞生成素、干扰素、人类生长激素和毛囊刺激素。 2021 年，胰岛素部门在蛋白质治疗市场中占据了可观的收入份额。这一细分市场的增长主要归因于全球糖尿病病例的增加。胰岛素是胰腺产生的一种天然激素。这种激素的生产不足是刺激人体糖尿病水平的一个因素。

应用前景

按应用，蛋白质治疗市场分为代谢疾病、免疫疾病、血液疾病、癌症、激素疾病、遗传疾病等。 2021 年，代谢疾病部门在蛋白质治疗市场中的收入份额最高。该细分市场增长的回升是由于对治疗疾病，尤其是糖尿病的高质量药物和适应性疗法的需求激增，预计这将支持该细分市场的增长。

区域展望

按地区分析了北美、欧洲、亚太地区和 LAMEA 的蛋白质治疗市场。 2021年，北美占蛋白质治疗市场最大的收入份额。这是由于慢性病发病率的增加、尖端疗法的使用、重要参与者的存在以及该地区医疗保健成本的上升。此外，北美国家是一些新技术和方法的早期采用者。

收购是市场参与者采取的主要策略。根据 Cardinal 矩阵中的分析，强生和辉瑞是蛋白质治疗市场的先驱。公司包括默克公司、Incorporated、安进和礼来公司。 Amgen, Inc.、Eli Lilly and Company 等公司是蛋白质治疗市场的主要创新者。

内容

第一章市场范围和研究方法

  • 市场定义
  • 目的
  • 市场规模
  • 细分
    • 全球蛋白质疗法市场，按产品分类
    • 全球蛋白质疗法市场，按应用
    • 按地区分列的全球蛋白质疗法市场
  • 调查方法

第 2 章市场概述

  • 简介
    • 简介
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动力
    • 市场製约因素

第 3 章竞争分析 - 世界

  • KBV 基数矩阵
  • 近期全行业的战略发展
    • 伙伴关係、合作和合同
    • 产品发布和产品扩展
    • 收购和合併
    • 产品发布和产品扩展
  • 关键成功策略
    • 主要领先战略：百分比分布（2018-2022）
    • 关键战略举措：（收购和合併：2018 年 3 月至 2022 年 6 月）主要参与者

第 4 章全球蛋白质疗法市场：按产品分类

  • 全球单克隆抗体市场：按地区
  • 全球人类生长激素市场：按地区
  • 全球融合蛋白市场：按地区
  • 世界胰岛素市场：按地区
  • 全球促红细胞生成素市场：按地区
  • 干扰素全球市场：按地区
  • 全球促卵泡激素市场：按地区划分

第 5 章全球蛋白质疗法市场：按应用分类

  • 按地区分列的全球代谢紊乱市场
  • 按地区分列的全球免疫系统疾病市场
  • 全球血液学市场：按地区
  • 全球癌症市场：按地区
  • 按地区分列的全球荷尔蒙失调市场
  • 按地区分列的全球遗传性疾病市场
  • 按地区划分的世界其他地区市场

第 6 章全球蛋白质疗法市场：按地区划分

  • 北美
    • 按国家/地区划分的北美蛋白质疗法市场
      • 美国
      • 加拿大
      • 墨西哥
      • 北美其他地区
  • 欧洲
    • 按国家/地区划分的欧洲蛋白质疗法市场
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲
  • 亚太地区
    • 亚太蛋白质疗法市场：按国家/地区分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • LAMEA
    • LAMEA 蛋白质疗法市场：按国家/地区分类
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其他 LAMEA

第七章公司简介

  • Abbott Laboratories
  • Baxter International, Inc.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly And Company
  • Merck & Co., Inc.
  • Johnson & Johnson（Janssen Global Services, LLC）
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.

The Global Protein Therapeutics Market size is expected to reach $490.2 billion by 2028, rising at a market growth of 6.9% CAGR during the forecast period.

Protein therapeutic medicines are a class of pharmaceuticals used to treat a range of illnesses, including cancer, metabolic, hematological, immunological, hormonal, genetic, contagious diseases, and others. These medications could greatly enhance human health. Protein distribution in appropriate amounts to the body to enable the precise functioning of various glands, as well as other organs in the body, is the basic concept behind protein therapy, which is conceptually related to gene therapy.

Genetically modified versions of naturally produced human proteins are called therapeutic proteins. They can be utilized to swap out proteins that are defective or lacking in a particular condition. They can also increase the supply of a helpful protein, which helps lessen the effects of chemotherapy or sickness. The proteins produced by genetic engineering can be made to closely match the natural proteins they are meant to replace, or they can be improved by the addition of sugars and other compounds that prolong the protein's activity.

A protein that is defective or lacking in a certain condition can be replaced with therapeutic proteins. They can also increase the body's production of a helpful protein to lessen the effects of illness or chemotherapy. The proteins produced by genetic engineering may closely resemble the natural proteins they are intended to replace, or they may be improved.

Covid-19 Impact Analysis

The COVID-19 pandemic severely hampered the economy all over the world. A number of businesses were significantly demolished by the abrupt emergence of the pandemic. Moreover, several manufacturing and production facilities were closed owing to the outbreak due to the lockdown imposed by various governments within their countries. The protein therapeutics market was also disrupted in the initial period of the pandemic. Lockdown caused major delays within the development and delivery of crucial medical supplies. Attributed to this, the production of therapeutic protein was impeded.

Market Growth Factors

An increase in the cases of cancer across the world

One of the major factors that are driving the growth of the protein therapeutics market is the expansion in the prevalence of various types of cancer all over the world. Any disease that can affect any region of the body is referred to as cancer. Neoplasms and malignant tumors are other words that are used to denote this disease. One characteristic of cancer is the quick development of aberrant cells that expand outside of their normal borders, infiltrate other body components, and eventually move to other organs. This process is known as metastasis. The main reason why cancer patients die is because of widespread metastases within their bodies.

Rising focus of governments and regulatory bodies in accelerating the process of approval for this practice

A significant number of people in various developed, as well as developing nations who suffer from uncommon and complex diseases, depend on plasma-derived therapies every day as essential, life-saving medications. The need for these treatments, in particular immunoglobulins, has grown significantly and is still growing on a global scale. Plasma-derived therapies are treatments made from human plasma through a fractionation procedure in which the pertinent plasma proteins are isolated. The single largest component of human blood is called plasma, which is made up of proteins, salts, enzymes, and water. Primary and secondary immunodeficiencies, bleeding disorders, inhibitor deficiencies, and other rare diseases are all treated with plasma-derived medicines.

Market Restraining Factors

High manufacturing and administration cost

A major challenge in the growth of the protein therapeutics market is the high cost of protein therapies. Because of high product prices, some therapies that patients need for a speedy and complete recovery are no longer available. In several nations, prices are additionally governed by law. Through their authority over national healthcare organizations, which can cover a significant portion of the cost of distributing drugs to consumers, government bodies restrict costs.

Product Outlook

On the basis of Product, the Protein Therapeutics Market is segmented into Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone. In 2021, the Insulin segment garnered a significant revenue share of the protein therapeutics market. The rise in the growth of the segment is majorly attributed to the increasing cases of diabetes all over the world. Insulin is a natural hormone, which is produced by the pancreas. The lack of production of this hormone is the factor that stimulates the diabetes level of the human body.

Application Outlook

By application, the Protein Therapeutics Market is segregated into Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others. In 2021, the metabolic disorders segment procured the biggest revenue share of the protein therapeutics market. The rise in the growth of the segment is due to the exponential demand for high-quality medications and adaptable therapies for the treatment of diseases, particularly diabetes, which is anticipated to support the segment's growth.

Regional Outlook

Region-wise, the Protein Therapeutics Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America held the largest revenue share of the protein therapeutics market. This is ascribed to an increase in the incidence of chronic diseases, the use of cutting-edge treatments, the presence of important players, and an increase in healthcare spending in the area. Moreover, North American countries are early adopters of several new technologies and approaches.

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson and Pfizer, Inc. are the forerunners in the Protein Therapeutics Market. Companies such as Merck & Co., Inc. Amgen, Inc., Eli Lilly and Company are some of the key innovators in Protein Therapeutics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Pfizer, Inc., Novo Nordisk A/S and Sanofi S.A.

Recent Strategies Deployed in Protein Therapeutics Market

Partnership, Collaboration and Agreements:

Aug-2022: Merck came into a collaboration with Orna Therapeutics, a biotechnology company. Following this collaboration, the companies would work on the discovery, development, and commercialization of multiple programs, encompassing therapeutics and vaccines in the sector of infectious disease and oncology.

Mar-2022: Novo Nordisk joined hands with Massachusetts Institutes of Technology and Brigham and Women's Hospital. Through this collaboration, the company aimed to leverage the distinct prospect to bring new transformational solutions to patients by utilizing its distinct capabilities.

Jan-2022: Amgen teamed up with Amgen Generate Biomedicines, a therapeutics company. Under this collaboration, the companies aimed to develop and manufacture protein therapeutics to address 5 clinical ailments.

Jan-2022: Merck teamed up with Absci, the drug, and target discovery company. Following this collaboration, Merck aimed to leverage Absci's platform to utilize its compelling opportunity intending to develop new biologic candidates as well as explore complex protein expression.

Aug-2021: Eli Lilly and Company joined hands with Lycia Therapeutics, a biotechnology company. Following this collaboration, the companies aimed to focus on the development, manufacturing, and marketing of new targeted therapeutics leveraging the proprietary lysosomal targeting chimera protein degradation technology of Lycia.

Sep-2020: Merck collaborated with Seattle Genetics, an American biotechnology company. With this collaboration, the companies aimed to further expand the oncology portfolio of Merck in order to enhance the lives of cancer patients.

Acquisition and Mergers:

Jun-2022: Pfizer took over ReViral, a privately held, clinical-stage biopharmaceutical company. Through this acquisition, the company aimed to integrate RSV investigational treatments of ReViral into its portfolio in order to acquire an offering of promising therapeutic candidates.

Nov-2021: Pfizer took over Trillium Therapeutics, a clinical-stage immuno-oncology company. This acquisition aimed to offer an impressive portfolio, including biologics, to Pfizer

Jul-2021: Amgen took over Teneobio, a clinical-stage biotechnology company. With this acquisition, the company aimed to leverage Teneobio's antibody platform in order to complement its prevailing capabilities. Moreover, the company also aimed to gain a diverse range of building blocks that can be created into new multispecific therapeutics.

Jul-2021: Eli Lilly and Company completed its acquisition of Protomer, a pre-clinical stage biotechnology company. Under this acquisition, the company aimed to help Protomer in enhancing its diabetes range with its innovative technology.

Feb-2021: Merck took over VelosBio, a privately held clinical-stage biopharmaceutical company. Through this acquisition, the company aimed to boost its expanding oncology portfolio while also strengthening its long-term growth potential.

Aug-2020: Johnson & Johnson completed its acquisition of Momenta Pharmaceuticals, a biotechnology company. This acquisition aimed to strengthen Janssen's position in the autoimmune diseases sector and offer a major catalyst for sustained growth of the company.

Approvals and Trials:

Sep-2020: Baxter International received the US FDA approval for its Clinimix and Clinimix E. The new formulations aimed to complement the offerings of medical formulations with their higher protein content.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Monoclonal Antibodies
  • Human Growth Hormone
  • Fusion Protein
  • Insulin
  • Erythropoietin
  • Interferon
  • Follicle Stimulating Hormone

By Application

  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Baxter International, Inc.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly And Company
  • Merck & Co., Inc.
  • Johnson & Johnson (Janssen Global Services, LLC)
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Protein Therapeutics Market, by Product
    • 1.4.2 Global Protein Therapeutics Market, by Application
    • 1.4.3 Global Protein Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Product Launches and Product Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Acquisition and Mergers: 2018, Mar - 2022, Jun) Leading Players

Chapter 4. Global Protein Therapeutics Market by Product

  • 4.1 Global Monoclonal Antibodies Market by Region
  • 4.2 Global Human Growth Hormone Market by Region
  • 4.3 Global Fusion Protein Market by Region
  • 4.4 Global Insulin Market by Region
  • 4.5 Global Erythropoietin Market by Region
  • 4.6 Global Interferon Market by Region
  • 4.7 Global Follicle Stimulating Hormone Market by Region

Chapter 5. Global Protein Therapeutics Market by Application

  • 5.1 Global Metabolic Disorders Market by Region
  • 5.2 Global Immunologic Disorders Market by Region
  • 5.3 Global Hematological Disorders Market by Region
  • 5.4 Global Cancer Market by Region
  • 5.5 Global Hormonal Disorders Market by Region
  • 5.6 Global Genetic Disorders Market by Region
  • 5.7 Global Others Market by Region

Chapter 6. Global Protein Therapeutics Market by Region

  • 6.1 North America Protein Therapeutics Market
    • 6.1.1 North America Protein Therapeutics Market by Product
      • 6.1.1.1 North America Monoclonal Antibodies Market by Country
      • 6.1.1.2 North America Human Growth Hormone Market by Country
      • 6.1.1.3 North America Fusion Protein Market by Country
      • 6.1.1.4 North America Insulin Market by Country
      • 6.1.1.5 North America Erythropoietin Market by Country
      • 6.1.1.6 North America Interferon Market by Country
      • 6.1.1.7 North America Follicle Stimulating Hormone Market by Country
    • 6.1.2 North America Protein Therapeutics Market by Application
      • 6.1.2.1 North America Metabolic Disorders Market by Country
      • 6.1.2.2 North America Immunologic Disorders Market by Country
      • 6.1.2.3 North America Hematological Disorders Market by Country
      • 6.1.2.4 North America Cancer Market by Country
      • 6.1.2.5 North America Hormonal Disorders Market by Country
      • 6.1.2.6 North America Genetic Disorders Market by Country
      • 6.1.2.7 North America Others Market by Country
    • 6.1.3 North America Protein Therapeutics Market by Country
      • 6.1.3.1 US Protein Therapeutics Market
        • 6.1.3.1.1 US Protein Therapeutics Market by Product
        • 6.1.3.1.2 US Protein Therapeutics Market by Application
      • 6.1.3.2 Canada Protein Therapeutics Market
        • 6.1.3.2.1 Canada Protein Therapeutics Market by Product
        • 6.1.3.2.2 Canada Protein Therapeutics Market by Application
      • 6.1.3.3 Mexico Protein Therapeutics Market
        • 6.1.3.3.1 Mexico Protein Therapeutics Market by Product
        • 6.1.3.3.2 Mexico Protein Therapeutics Market by Application
      • 6.1.3.4 Rest of North America Protein Therapeutics Market
        • 6.1.3.4.1 Rest of North America Protein Therapeutics Market by Product
        • 6.1.3.4.2 Rest of North America Protein Therapeutics Market by Application
  • 6.2 Europe Protein Therapeutics Market
    • 6.2.1 Europe Protein Therapeutics Market by Product
      • 6.2.1.1 Europe Monoclonal Antibodies Market by Country
      • 6.2.1.2 Europe Human Growth Hormone Market by Country
      • 6.2.1.3 Europe Fusion Protein Market by Country
      • 6.2.1.4 Europe Insulin Market by Country
      • 6.2.1.5 Europe Erythropoietin Market by Country
      • 6.2.1.6 Europe Interferon Market by Country
      • 6.2.1.7 Europe Follicle Stimulating Hormone Market by Country
    • 6.2.2 Europe Protein Therapeutics Market by Application
      • 6.2.2.1 Europe Metabolic Disorders Market by Country
      • 6.2.2.2 Europe Immunologic Disorders Market by Country
      • 6.2.2.3 Europe Hematological Disorders Market by Country
      • 6.2.2.4 Europe Cancer Market by Country
      • 6.2.2.5 Europe Hormonal Disorders Market by Country
      • 6.2.2.6 Europe Genetic Disorders Market by Country
      • 6.2.2.7 Europe Others Market by Country
    • 6.2.3 Europe Protein Therapeutics Market by Country
      • 6.2.3.1 Germany Protein Therapeutics Market
        • 6.2.3.1.1 Germany Protein Therapeutics Market by Product
        • 6.2.3.1.2 Germany Protein Therapeutics Market by Application
      • 6.2.3.2 UK Protein Therapeutics Market
        • 6.2.3.2.1 UK Protein Therapeutics Market by Product
        • 6.2.3.2.2 UK Protein Therapeutics Market by Application
      • 6.2.3.3 France Protein Therapeutics Market
        • 6.2.3.3.1 France Protein Therapeutics Market by Product
        • 6.2.3.3.2 France Protein Therapeutics Market by Application
      • 6.2.3.4 Russia Protein Therapeutics Market
        • 6.2.3.4.1 Russia Protein Therapeutics Market by Product
        • 6.2.3.4.2 Russia Protein Therapeutics Market by Application
      • 6.2.3.5 Spain Protein Therapeutics Market
        • 6.2.3.5.1 Spain Protein Therapeutics Market by Product
        • 6.2.3.5.2 Spain Protein Therapeutics Market by Application
      • 6.2.3.6 Italy Protein Therapeutics Market
        • 6.2.3.6.1 Italy Protein Therapeutics Market by Product
        • 6.2.3.6.2 Italy Protein Therapeutics Market by Application
      • 6.2.3.7 Rest of Europe Protein Therapeutics Market
        • 6.2.3.7.1 Rest of Europe Protein Therapeutics Market by Product
        • 6.2.3.7.2 Rest of Europe Protein Therapeutics Market by Application
  • 6.3 Asia Pacific Protein Therapeutics Market
    • 6.3.1 Asia Pacific Protein Therapeutics Market by Product
      • 6.3.1.1 Asia Pacific Monoclonal Antibodies Market by Country
      • 6.3.1.2 Asia Pacific Human Growth Hormone Market by Country
      • 6.3.1.3 Asia Pacific Fusion Protein Market by Country
      • 6.3.1.4 Asia Pacific Insulin Market by Country
      • 6.3.1.5 Asia Pacific Erythropoietin Market by Country
      • 6.3.1.6 Asia Pacific Interferon Market by Country
      • 6.3.1.7 Asia Pacific Follicle Stimulating Hormone Market by Country
    • 6.3.2 Asia Pacific Protein Therapeutics Market by Application
      • 6.3.2.1 Asia Pacific Metabolic Disorders Market by Country
      • 6.3.2.2 Asia Pacific Immunologic Disorders Market by Country
      • 6.3.2.3 Asia Pacific Hematological Disorders Market by Country
      • 6.3.2.4 Asia Pacific Cancer Market by Country
      • 6.3.2.5 Asia Pacific Hormonal Disorders Market by Country
      • 6.3.2.6 Asia Pacific Genetic Disorders Market by Country
      • 6.3.2.7 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Protein Therapeutics Market by Country
      • 6.3.3.1 China Protein Therapeutics Market
        • 6.3.3.1.1 China Protein Therapeutics Market by Product
        • 6.3.3.1.2 China Protein Therapeutics Market by Application
      • 6.3.3.2 Japan Protein Therapeutics Market
        • 6.3.3.2.1 Japan Protein Therapeutics Market by Product
        • 6.3.3.2.2 Japan Protein Therapeutics Market by Application
      • 6.3.3.3 India Protein Therapeutics Market
        • 6.3.3.3.1 India Protein Therapeutics Market by Product
        • 6.3.3.3.2 India Protein Therapeutics Market by Application
      • 6.3.3.4 South Korea Protein Therapeutics Market
        • 6.3.3.4.1 South Korea Protein Therapeutics Market by Product
        • 6.3.3.4.2 South Korea Protein Therapeutics Market by Application
      • 6.3.3.5 Singapore Protein Therapeutics Market
        • 6.3.3.5.1 Singapore Protein Therapeutics Market by Product
        • 6.3.3.5.2 Singapore Protein Therapeutics Market by Application
      • 6.3.3.6 Malaysia Protein Therapeutics Market
        • 6.3.3.6.1 Malaysia Protein Therapeutics Market by Product
        • 6.3.3.6.2 Malaysia Protein Therapeutics Market by Application
      • 6.3.3.7 Rest of Asia Pacific Protein Therapeutics Market
        • 6.3.3.7.1 Rest of Asia Pacific Protein Therapeutics Market by Product
        • 6.3.3.7.2 Rest of Asia Pacific Protein Therapeutics Market by Application
  • 6.4 LAMEA Protein Therapeutics Market
    • 6.4.1 LAMEA Protein Therapeutics Market by Product
      • 6.4.1.1 LAMEA Monoclonal Antibodies Market by Country
      • 6.4.1.2 LAMEA Human Growth Hormone Market by Country
      • 6.4.1.3 LAMEA Fusion Protein Market by Country
      • 6.4.1.4 LAMEA Insulin Market by Country
      • 6.4.1.5 LAMEA Erythropoietin Market by Country
      • 6.4.1.6 LAMEA Interferon Market by Country
      • 6.4.1.7 LAMEA Follicle Stimulating Hormone Market by Country
    • 6.4.2 LAMEA Protein Therapeutics Market by Application
      • 6.4.2.1 LAMEA Metabolic Disorders Market by Country
      • 6.4.2.2 LAMEA Immunologic Disorders Market by Country
      • 6.4.2.3 LAMEA Hematological Disorders Market by Country
      • 6.4.2.4 LAMEA Cancer Market by Country
      • 6.4.2.5 LAMEA Hormonal Disorders Market by Country
      • 6.4.2.6 LAMEA Genetic Disorders Market by Country
      • 6.4.2.7 LAMEA Others Market by Country
    • 6.4.3 LAMEA Protein Therapeutics Market by Country
      • 6.4.3.1 Brazil Protein Therapeutics Market
        • 6.4.3.1.1 Brazil Protein Therapeutics Market by Product
        • 6.4.3.1.2 Brazil Protein Therapeutics Market by Application
      • 6.4.3.2 Argentina Protein Therapeutics Market
        • 6.4.3.2.1 Argentina Protein Therapeutics Market by Product
        • 6.4.3.2.2 Argentina Protein Therapeutics Market by Application
      • 6.4.3.3 UAE Protein Therapeutics Market
        • 6.4.3.3.1 UAE Protein Therapeutics Market by Product
        • 6.4.3.3.2 UAE Protein Therapeutics Market by Application
      • 6.4.3.4 Saudi Arabia Protein Therapeutics Market
        • 6.4.3.4.1 Saudi Arabia Protein Therapeutics Market by Product
        • 6.4.3.4.2 Saudi Arabia Protein Therapeutics Market by Application
      • 6.4.3.5 South Africa Protein Therapeutics Market
        • 6.4.3.5.1 South Africa Protein Therapeutics Market by Product
        • 6.4.3.5.2 South Africa Protein Therapeutics Market by Application
      • 6.4.3.6 Nigeria Protein Therapeutics Market
        • 6.4.3.6.1 Nigeria Protein Therapeutics Market by Product
        • 6.4.3.6.2 Nigeria Protein Therapeutics Market by Application
      • 6.4.3.7 Rest of LAMEA Protein Therapeutics Market
        • 6.4.3.7.1 Rest of LAMEA Protein Therapeutics Market by Product
        • 6.4.3.7.2 Rest of LAMEA Protein Therapeutics Market by Application

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Baxter International, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Approvals and Trials:
      • 7.2.5.2 Acquisition and Mergers:
  • 7.3 Amgen, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Partnerships, Collaborations, and Agreements:
      • 7.3.5.2 Acquisition and Mergers:
  • 7.4 F. Hoffmann-La Roche Ltd.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 Eli Lilly And Company
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expenses
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Partnerships, Collaborations, and Agreements:
      • 7.5.5.2 Acquisition and Mergers:
  • 7.6 Merck & Co., Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Partnerships, Collaborations, and Agreements:
      • 7.6.5.2 Acquisition and Mergers:
  • 7.7 Johnson & Johnson (Janssen Global Services, LLC)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental &Regional Analysis
    • 7.7.4 Research & Development Expenses
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Product Launches and Product Expansions:
      • 7.7.5.2 Acquisition and Mergers:
  • 7.8 Pfizer, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional & Segmental Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Acquisition and Mergers:
  • 7.9 Novo Nordisk A/S
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental & Regional Analysis
    • 7.9.4 Research & Development Expenses
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Partnerships, Collaborations, and Agreements:
  • 7.10. Sanofi S.A.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 Global Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 2 Global Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Protein Therapeutics Market
  • TABLE 4 Product Launches And Product Expansions- Protein Therapeutics Market
  • TABLE 5 Acquisition and Mergers- Protein Therapeutics Market
  • TABLE 6 Trial and Approvals- Protein Therapeutics Market
  • TABLE 7 Global Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 8 Global Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 9 Global Monoclonal Antibodies Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Monoclonal Antibodies Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Human Growth Hormone Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Human Growth Hormone Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Fusion Protein Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Fusion Protein Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Insulin Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Insulin Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Erythropoietin Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Erythropoietin Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Interferon Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Interferon Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Follicle Stimulating Hormone Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Follicle Stimulating Hormone Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 24 Global Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 25 Global Metabolic Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Metabolic Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Immunologic Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Immunologic Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Hematological Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Hematological Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Hormonal Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Hormonal Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 35 Global Genetic Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 36 Global Genetic Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 37 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 38 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 39 Global Protein Therapeutics Market by Region, 2018 - 2021, USD Million
  • TABLE 40 Global Protein Therapeutics Market by Region, 2022 - 2028, USD Million
  • TABLE 41 North America Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 42 North America Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 43 North America Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 44 North America Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 45 North America Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Human Growth Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Human Growth Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Fusion Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Fusion Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Insulin Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Insulin Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Interferon Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Interferon Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 60 North America Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 61 North America Metabolic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Metabolic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Immunologic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Immunologic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Hematological Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 66 North America Hematological Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 67 North America Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 69 North America Hormonal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 70 North America Hormonal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 71 North America Genetic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 72 North America Genetic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 73 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 74 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 75 North America Protein Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 76 North America Protein Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 77 US Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 78 US Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 79 US Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 80 US Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 81 US Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 82 US Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 83 Canada Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 84 Canada Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 85 Canada Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 86 Canada Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 87 Canada Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 88 Canada Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 89 Mexico Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 90 Mexico Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 91 Mexico Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 92 Mexico Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 93 Mexico Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 94 Mexico Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 95 Rest of North America Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 96 Rest of North America Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 97 Rest of North America Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 98 Rest of North America Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 99 Rest of North America Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 100 Rest of North America Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 101 Europe Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 102 Europe Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 103 Europe Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 104 Europe Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 105 Europe Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Human Growth Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Human Growth Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Fusion Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Fusion Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Insulin Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Insulin Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Interferon Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Interferon Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Europe Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 120 Europe Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 121 Europe Metabolic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Metabolic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Europe Immunologic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 124 Europe Immunologic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 125 Europe Hematological Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 126 Europe Hematological Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 127 Europe Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Europe Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Europe Hormonal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Europe Hormonal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Europe Genetic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Europe Genetic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Europe Protein Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 136 Europe Protein Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 137 Germany Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 138 Germany Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 139 Germany Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 140 Germany Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 141 Germany Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 142 Germany Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 143 UK Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 144 UK Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 145 UK Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 146 UK Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 147 UK Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 148 UK Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 149 France Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 150 France Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 151 France Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 152 France Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 153 France Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 154 France Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 155 Russia Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 156 Russia Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 157 Russia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 158 Russia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 159 Russia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 160 Russia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 161 Spain Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 162 Spain Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 163 Spain Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 164 Spain Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 165 Spain Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 166 Spain Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 167 Italy Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 168 Italy Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 169 Italy Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 170 Italy Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 171 Italy Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 172 Italy Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 173 Rest of Europe Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 174 Rest of Europe Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 175 Rest of Europe Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 176 Rest of Europe Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 177 Rest of Europe Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 178 Rest of Europe Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Human Growth Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Human Growth Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Fusion Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Fusion Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Insulin Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Insulin Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Interferon Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Interferon Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Metabolic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Metabolic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Immunologic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Immunologic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Hematological Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Hematological Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Hormonal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Hormonal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Asia Pacific Genetic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 210 Asia Pacific Genetic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 211 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 212 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 213 Asia Pacific Protein Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 214 Asia Pacific Protein Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 215 China Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 216 China Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 217 China Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 218 China Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 219 China Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 220 China Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 221 Japan Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 222 Japan Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 223 Japan Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 224 Japan Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 225 Japan Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 226 Japan Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 227 India Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 228 India Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 229 India Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 230 India Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 231 India Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 232 India Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 233 South Korea Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 234 South Korea Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 235 South Korea Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 236 South Korea Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 237 South Korea Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 238 South Korea Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 239 Singapore Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 240 Singapore Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 241 Singapore Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 242 Singapore Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 243 Singapore Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 244 Singapore Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 245 Malaysia Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 246 Malaysia Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 247 Malaysia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 248 Malaysia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 249 Malaysia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 250 Malaysia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 251 Rest of Asia Pacific Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 252 Rest of Asia Pacific Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 253 Rest of Asia Pacific Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 254 Rest of Asia Pacific Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 255 Rest of Asia Pacific Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 256 Rest of Asia Pacific Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Human Growth Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Human Growth Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Fusion Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Fusion Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Insulin Market by Country, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Insulin Market by Country, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Interferon Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Interferon Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Metabolic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Metabolic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Immunologic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Immunologic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Hematological Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Hematological Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Hormonal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Hormonal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA Genetic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA Genetic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Protein Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Protein Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 293 Brazil Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 294 Brazil Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 295 Brazil Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 296 Brazil Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 297 Brazil Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 298 Brazil Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 299 Argentina Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 300 Argentina Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 301 Argentina Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 302 Argentina Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 303 Argentina Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 304 Argentina Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 305 UAE Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 306 UAE Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 307 UAE Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 308 UAE Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 309 UAE Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 310 UAE Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 311 Saudi Arabia Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 312 Saudi Arabia Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 313 Saudi Arabia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 314 Saudi Arabia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 315 Saudi Arabia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 316 Saudi Arabia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 317 South Africa Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 318 South Africa Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 319 South Africa Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 320 South Africa Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 321 South Africa Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 322 South Africa Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 323 Nigeria Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 324 Nigeria Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 325 Nigeria Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 326 Nigeria Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 327 Nigeria Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 328 Nigeria Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 329 Rest of LAMEA Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 330 Rest of LAMEA Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 331 Rest of LAMEA Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 332 Rest of LAMEA Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 333 Rest of LAMEA Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 334 Rest of LAMEA Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 335 Key Information - Abbott Laboratories
  • TABLE 336 Key Information - Baxter International, Inc.
  • TABLE 337 Key Information - Amgen, Inc.
  • TABLE 338 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 339 Key Information - Eli Lilly And Company
  • TABLE 340 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 341 Key information -Johnson & Johnson
  • TABLE 342 Key Information - Pfizer, Inc.
  • TABLE 343 Key information - Novo Nordisk A/S
  • TABLE 344 Key Information - Sanofi S.A.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
  • FIG 4 Key Strategic Move: (Acquisition and Mergers: 2018, Mar - 2022, Jun) Leading Players
  • FIG 5 Global Protein Therapeutics Market Share by Product, 2021
  • FIG 6 Global Protein Therapeutics Market Share by Product, 2028
  • FIG 7 Global Protein Therapeutics Market by Product, 2018 - 2028, USD Million
  • FIG 8 Global Protein Therapeutics Market Share by Application, 2021
  • FIG 9 Global Protein Therapeutics Market Share by Application, 2028
  • FIG 10 Global Protein Therapeutics Market by Application, 2018 - 2028, USD Million
  • FIG 11 Global Protein Therapeutics Market Share by Region, 2021
  • FIG 12 Global Protein Therapeutics Market Share by Region, 2028
  • FIG 13 Global Protein Therapeutics Market by Region, 2018 - 2028, USD Million
  • FIG 14 Swot analysis: Abbott laboratories
  • FIG 15 Recent strategies and developments: Merck & Co., Inc.